MedPath

Body Responses to Bean Physical Form and "Beano"

Not Applicable
Completed
Conditions
Appetite and Glucose Responses
Interventions
Other: blended lentils
Other: whole lentils
Other: no lentils
Registration Number
NCT02110511
Lead Sponsor
Purdue University
Brief Summary

The aim of this study is to determine the effects of bean physical form (whole versus blended) and Beano on postprandial responses. The postprandial responses the investigators will examine include blood glucose, appetite, metabolic rate, physical symptoms, and mood. To accomplish this aim the investigators will conduct a randomized, placebo-controlled trial in overweight and obese but otherwise healthy (non-diabetic) men and women

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Aged 18-55 years old
  • Body mass index (BMI) 18.5-40 kg/m2
  • Generally healthy
  • A non-smoker
  • Any ethnicity
  • Free of chronic diseases and not taking medications or dietary supplements known to affect energy regulation or appetite
Exclusion Criteria
  • Beano drug label warnings including galactosemia, severe liver or kidney disease, allergies or sensitivities to any of the ingredients in Beano
  • Peri and postmenopausal women
  • Pregnant or lactating women (currently and within the past 1 year)
  • Currently dieting or consuming unusual or a medically prescribed diet
  • Net weight loss or gain (>5 lbs) within the last six months
  • Consuming 1/2c per day or more of legumes, not including peanuts
  • Having taken Beano any time in the past 3 months
  • Extreme problems digesting beans
  • Fasting glucose >126 mg/dl
  • Blood pressure >140/90 mmHg
  • Moderate intensity or higher intensity exercise > 6 h/wk
  • Predicted energy requirement < 2000 kcal/d or >4000 kcal/d

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
alpha-gal & blended lentilsblended lentils3 capsules of alpha-gal taken with blended lentils
alpha-gal & whole lentilswhole lentils3 calpsules of alpha-gal taken with whole lentils
alpha-gal & no lentilsno lentils3 capsules of alpha-gal taken with no lentils control
Placebo & blended lentilsblended lentils3 capsules of placebo taken with blended lentils
Placebo & whole lentilswhole lentils3 capsules of placebo taken with whole lentils
Placebo & no lentilsno lentils3 capsules of placebo taken with no lentils control
Primary Outcome Measures
NameTimeMethod
Appetite3 hours

Subjects were given an appetite questionnaire to complete at time 0, 20, 40, 60, 120 and 180

Secondary Outcome Measures
NameTimeMethod
Blood glucose3 hours

Finger prick blood were taken at time 0, 20, 40, 60, 120 and 180 for glucose measurement using a glucometer

fasting and postprandial energy expentidure4 hours

Fasting energy expenditure was measured for thirty minutes before meal and beano intervensions were given and at postprandial time points 20, 40, 60, 120 and 180, postprandial energy expenditure was measured for 15 minutes at each time point

gastrointestinal symptoms3 hours

At timepoints 0, 20, 40, 60, 120 and 180, gastroinstinal symptoms were assessed using a questionnaire

Trial Locations

Locations (1)

Purdue University

🇺🇸

West Lafayette, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath